Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Other Non Operating Income (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Other Non Operating Income came in at -$147000.0 in Q2 2026, up 94.89% on a YoY basis from -$75428.3 in Q2 2025, and down 115.14% quarter-over-quarter from $971000.0 in Q1 2026.

Analysis

Medpace Holdings (MEDP) Other Non Operating Income (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Other Non Operating Income for 12 consecutive years, with -$147000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non Operating Income rose 94.89% year-over-year to -$147000.0; the trailing twelve-month figure through Jun 2026 stood at $177000.0 (up 103.47% YoY), and the FY2025 full-year result was -$5.3 million, down 231.61% from the prior year.
  • Other Non Operating Income fell to -$147000.0 in Q2 2026 per MEDP's latest filing, from $971000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $5.6 million in Q3 2022 and bottomed at -$2.9 million in Q2 2025.
  • Historically, Other Non Operating Income has averaged $330833.3 across 5 years, with a median of -$140000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 772.08% in 2022, then sank 2061.65% in 2025.
  • Over 5 years, Other Non Operating Income stood at -$2.0 million in 2022, then soared by 178.76% to $1.5 million in 2023, then sank by 59.75% to $621000.0 in 2024, then plunged by 125.44% to -$158000.0 in 2025, then gained by 6.96% to -$147000.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$147000.0, $971000.0, and -$158000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -147,000.00
Mar 31, 2026 971,000.00
Dec 31, 2025 -158,000.00
Sep 30, 2025 -489,000.00
Jun 30, 2025 -2.88 Mn
Mar 31, 2025 -1.82 Mn
Dec 31, 2024 621,000.00
Sep 30, 2024 -1.03 Mn
Jun 30, 2024 -133,000.00
Mar 31, 2024 4.59 Mn
Dec 31, 2023 1.54 Mn
Sep 30, 2023 -1.60 Mn
Jun 30, 2023 -1.28 Mn
Mar 31, 2023 687,000.00
Dec 31, 2022 -1.96 Mn
Sep 30, 2022 5.65 Mn
Jun 30, 2022 2.31 Mn
Mar 31, 2022 1.07 Mn
Dec 31, 2021 1.09 Mn
Sep 30, 2021 1.06 Mn